-
EP4121068
European procedure
- EP About this file
- EP Legal status
- EP Federated register
- EP Event history
- EP Citations
- EP Patent family
- EP All documents
Extract from the Register of European Patents
EP About this file: EP4121068
| EP4121068 - V DELTA1+ T CELLS FOR THE TREATMENT OF MYELOID MALIGNANCIES [Right-click to bookmark this link] | Status | Examination is in progress Status updated on 12.04.2024 Database last updated on 31.08.2024 | |
| Former | Request for examination was made Status updated on 23.12.2022 | ||
| Former | The international publication has been made Status updated on 24.09.2021 | ||
| Former | unknown Status updated on 19.05.2020 | Most recent event Tooltip | 10.08.2024 | Change: Despatch of examination report + time limit | Applicant(s) | For all designated states GammaDelta Therapeutics Limited WestWorks 195 Wood Lane White City Place London W12 7FQ / GB | [2023/04] | Inventor(s) | 01 /
SIMOES, Andre Goncalo do Espirito Santo GammaDelta Therapeutics Limited WestWorks 195 Wood Lane White City Place London W12 7FQ / GB | 02 /
DI LORENZO, Biagio GammaDelta Therapeutics Limited WestWorks 195 Wood Lane White City Place London W12 7FQ / GB | 03 /
KOSLOWSKI, Michael GammaDelta Therapeutics Limited WestWorks 195 Wood Lane White City Place London W12 7FQ / GB | 04 /
SILVA-SANTOS, Bruno Miguel de Carvalho e GammaDelta Therapeutics Limited WestWorks 195 Wood Lane White City Place London W12 7FQ / GB | 05 /
HUTTON, Andrew John GammaDelta Therapeutics Limited WestWorks 195 Wood Lane White City Place London W12 7FQ / GB | 06 /
RECALDIN, Timothy Joel GammaDelta Therapeutics Limited WestWorks 195 Wood Lane White City Place London W12 7FQ / GB | 07 /
FOWLER, Daniel GammaDelta Therapeutics Limited WestWorks 195 Wood Lane White City Place London W12 7FQ / GB | 08 /
BROMLEY, Alice GammaDelta Therapeutics Limited WestWorks 195 Wood Lane White City Place London W12 7FQ / GB | 09 /
NUSSBAUMER, Oliver GammaDelta Therapeutics Limited WestWorks 195 Wood Lane White City Place London W12 7FQ / GB | [2023/04] | Representative(s) | Sagittarius IP Marlow International Parkway Marlow SL7 1YL / GB | [N/P] |
| Former [2023/04] | Pond, Elizabeth Grace Catherine Sagittarius IP Marlow International Parkway Marlow SL7 1YL / GB | Application number, filing date | 20724903.8 | 20.03.2020 | [2023/04] | WO2020GB50763 | Filing language | EN | Procedural language | EN | Publication | Type: | A1 Application with search report | No.: | WO2021186137 | Date: | 23.09.2021 | Language: | EN | [2021/38] | Type: | A1 Application with search report | No.: | EP4121068 | Date: | 25.01.2023 | Language: | EN | The application published by WIPO in one of the EPO official languages on 23.09.2021 takes the place of the publication of the European patent application. | [2023/04] | Search report(s) | International search report - published on: | EP | 23.09.2021 | Classification | IPC: | A61K35/17, A61K31/675, A61K31/7076, A61K45/06, A61P35/02, C12N5/00 | [2023/04] | CPC: |
A61K45/06 (EP,IL,KR);
C12N5/0638 (EP,IL,KR,US);
A61K35/17 (KR);
A61K2239/31 (EP,IL,US);
A61K2239/38 (EP,IL,US);
A61K2239/48 (EP,IL,US);
A61K31/675 (EP,IL,KR,US);
A61K31/7076 (EP,IL,KR,US);
A61K39/4611 (EP,IL,US);
A61K39/4644 (EP,IL,US);
A61P35/02 (EP,IL,KR,US);
A61K2300/00 (IL,KR);
C12N2501/2301 (US);
C12N2501/2304 (US);
C12N2501/2315 (US);
| C-Set: |
A61K31/675, A61K2300/00 (EP);
A61K31/7076, A61K2300/00 (EP) | Designated contracting states | AL, AT, BE, BG, CH, CY, CZ, DE, DK, EE, ES, FI, FR, GB, GR, HR, HU, IE, IS, IT, LI, LT, LU, LV, MC, MK, MT, NL, NO, PL, PT, RO, RS, SE, SI, SK, SM, TR [2023/04] | Title | German: | V DELTA1+ T ZELLEN ZUR BEHANDLUNG VON MYELOIDEN MALIGNOMEN | [2023/04] | English: | V DELTA1+ T CELLS FOR THE TREATMENT OF MYELOID MALIGNANCIES | [2023/04] | French: | LYMPHOCYTES T V DELTA1+ POUR LE TRAITEMENT DE MALIGNITÉS MYÉLOÏDES | [2023/04] | Entry into regional phase | 13.10.2022 | National basic fee paid | 13.10.2022 | Designation fee(s) paid | 13.10.2022 | Examination fee paid | Examination procedure | 13.10.2022 | Examination requested [2023/04] | 13.10.2022 | Date on which the examining division has become responsible | 07.06.2023 | Despatch of communication that the application is deemed to be withdrawn, reason: reply to the Extended European Search Report/Written Opinion of the International Searching Authority/International Preliminary Examination Report/Supplementary international search report not received in time | 07.06.2023 | Despatch of communication of loss of particular rights: Claims {1} | 16.08.2023 | Amendment by applicant (claims and/or description) | 12.04.2024 | Despatch of a communication from the examining division (Time limit: M06) | Request for further processing for: | 16.08.2023 | Request for further processing filed | 16.08.2023 | Full payment received (date of receipt of payment) Request granted | 24.08.2023 | Decision despatched | Fees paid | Renewal fee | 13.10.2022 | Renewal fee patent year 03 | 22.03.2023 | Renewal fee patent year 04 | 20.03.2024 | Renewal fee patent year 05 |
| Opt-out from the exclusive Tooltip competence of the Unified Patent Court | See the Register of the Unified Patent Court for opt-out data | ||
| Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court. | Cited in | International search | [XDY]WO2016198480 (LYMPHACT - LYMPHOCYTE ACTIVATION TECH S A [PT]); | by applicant | WO2005035728 | US9255243 | WO2016198480 | WO2017072367 | WO2018202808 |